Report overview
The global Secukinumab market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
Patent segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Secukinumab include Carbosynth, TargetMol Chemicals, Changzhou Chenhong Biotechnology, DC Chemicals, Huatesheng Biotechnology, Hubei Guangao Biotechnology, Hubei Kele Fine Chemical, Hubei Widely Chemical Technology, Hubei Xingcheng Biotechnology, Hubei Zhongshan Medical Technology, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Secukinumab manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Secukinumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Secukinumab. This report contains market size and forecasts of Secukinumab in global, including the following market information:
Global Secukinumab market revenue, 2020-2025, 2026-2032, ($ millions)
Global Secukinumab market sales, 2020-2025, 2026-2032, (Kg)
Global top five Secukinumab companies in 2024 (%)
Total Market by Segment:
Global Secukinumab market, by Type, 2020-2025, 2026-2032 ($ millions) & (Kg)
Global Secukinumab market segment percentages, by Type, 2024 (%)
Patent
Generic
Global Secukinumab market, by Application, 2020-2025, 2026-2032 ($ Millions) & (Kg)
Global Secukinumab market segment percentages, by Application, 2024 (%)
Chemical
Pharmaceutical
Global Secukinumab market, by region and country, 2020-2025, 2026-2032 ($ millions) & (Kg)
Global Secukinumab market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Secukinumab revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Secukinumab revenues share in global market, 2024 (%)
Key companies Secukinumab sales in global market, 2020-2025 (estimated), (Kg)
Key companies Secukinumab sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Carbosynth
TargetMol Chemicals
Changzhou Chenhong Biotechnology
DC Chemicals
Huatesheng Biotechnology
Hubei Guangao Biotechnology
Hubei Kele Fine Chemical
Hubei Widely Chemical Technology
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Jiangxi Ruiweier Biotechnology
Nantong Hi-Future Biotechnology
Shanghai Biochempartner
Shanghai Minkai Biotechnology
Shanghai Yifei Biotechnology
Shanghai Yu'ang Chemical
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
WeiShi Reagent
Wuhan Dingxintong Pharmaceutical
Wuhan Fortuna Chemical
Wuhan Topule Biopharmaceutical
Wuhan Weisman Bioengineering
Wuhan Yingnuo Pharmaceutical Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Secukinumab, market overview.
Chapter 2: Global Secukinumab market size in revenue and volume.
Chapter 3: Detailed analysis of Secukinumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Secukinumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Secukinumab capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
